Abstract | Protein-energy wasting (PEW), which is manifested by low serum levels of albumin or prealbumin, sarcopenia and weight loss, is one of the strongest predictors of mortality in patients with chronic kidney disease (CKD). Although PEW might be engendered by non-nutritional conditions, such as inflammation or other comorbidities, the question of causality does not refute the effectiveness of dietary interventions and nutritional support in improving outcomes in patients with CKD. The literature indicates that PEW can be mitigated or corrected with an appropriate diet and enteral nutritional support that targets dietary protein intake. In-center meals or oral supplements provided during dialysis therapy are feasible and inexpensive interventions that might improve survival and quality of life in patients with CKD. Dietary requirements and enteral nutritional support must also be considered in patients with CKD and diabetes mellitus, in patients undergoing peritoneal dialysis, renal transplant recipients, and in children with CKD. Adjunctive pharmacological therapies, such as appetite stimulants, anabolic hormones, and antioxidative or antiinflammatory agents, might augment dietary interventions. Intraperitoneal or intradialytic parenteral nutrition should be considered for patients with PEW whenever enteral interventions are not possible or are ineffective. Controlled trials are needed to better assess the effectiveness of in-center meals and oral supplements.
Introduction
Overnutrition is a major problem in the general popula tion and a serious risk factor for developing metabolic syndrome, cardiovascular disease and chronic kidney disease (CKD), with a subsequent increase in risk of mortality. By contrast, in patients with CKD, and especially in those undergoing maintenance dialysis, the socalled uremic malnutrition 1 (also referred to as proteinenergy wasting [PEW] ) 2 is by far the strongest risk factor for adverse outcomes and death; 3 surrogates of overnutrition such as obesity or hyperlipidemia seem, counterintuitively, to be associated with increased sur vival. 4 Similar associations have been described in individuals with other chronic disease states, such as respiratory failure and heart failure, 5, 6 or in the elderly population. 7 In CKD and other chronic diseases that are associated with wasting syndrome, it is believed that pathophysiological pathways associated with malnutri tion are killers in the shortterm and render risk factors such as obesity or hypertension practically irrele vant with regard to their contribution to mortality. In other words, patients undergoing dialysis die of the shortterm consequences of PEW and do not live long enough to die of risk factors associated with overnutrition. This 'time discrepancy hypothesis' 8 suggests that, in a patient with CKD whose risk of shortterm mortality is high, inter ventions that improve nutritional status and prevent or correct wasting and sarcopenia have the potential to save lives, as compared with conventional interventions such as treating hypercholesterolemia, hypertension or obesity. Indeed, two randomized, controlled trials have shown that lowering cholesterol in patients on dialy sis with hyperlipidemia has no effect on survival. 9 ,10 A 10year cohort study in 206 patients undergoing hemo dialysis indicated that serum albumin concentration was far superior as a predictor of mortality than inflamma tory markers or intima-media thickness of the common carotid artery. 11 PEW seems, therefore, to be a strong predictor of mortality in patients with CKD, and improv ing nutritional status by dietary and non dietary inter ventions could be an important step towards improving outcomes in CKD. In this Review, we will focus on the dietary and enteral management of CKD as an important component of patient care. Parenteral and non dietary interventions, including adjunctive therapies, are also mentioned briefly. albumin concentration of 2 g/l above or below that of another patient with similar demographic features and comorbidities has a substantially decreased or increased risk of death, respectively.
The association between serum albumin levels and mortality is highly incremental and linear, and the mortal ity predictability of a serum albumin concentra tion of <40 g/l has virtually no cutoff level below which the association with death would cease or reverse. 14, 15 This association is in sharp contrast to most other predictors of outcome in CKD, which have Ushaped or Jshaped survival associations. More importantly, changes in serum levels of albumin over time are associ ated with propor tional and reciprocal alterations in the risk of mortality, in that an increase or decrease in serum albumin concentra tion of as little as 1 g/l over a period of a few months is associated with increased or decreased survival, respec tively ( Figure 2 ).
14 Similar predictors of mortality have been reported with other nutritional markers, such as serum prealbumin concentration (<300 mg/l) 16, 17 and a malnutrition-inflammation score of ≥5. 18 Nevertheless, measuring serum levels of albumin remains the simplest test that is readily available. Given all of the above, serum levels of albumin and prealbumin and other measures of nutritional status seem to be reliable indicators of perform ance measures in patients with CKD, especially if it can be shown that an increase in serum levels of albumin or prealbumin by feasible interventions would lead to an improvement in nutritional status and outcomes.
Hypoalbuminemia: marker of PEW or inflammation?
At any given time, approximately twothirds of all patients on dialysis in the USA exhibit hypo albuminemia, that is, a serum albumin concentration of <40 g/l (based on the bromocresol green technique), which is used to diagnose PEW as suggested by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. 19 Hypoalbuminemia is at least as prevalent in the early stages of CKD as in patients undergoing dialysis; a study of 1,220 patients with nondialysisdependent CKD found that 74% of patients had a serum albumin concentra tion of <40 g/l, and 55% of patients had a concentration of <38 g/l. 20 A low serum albumin concentration in patients with CKD could be related to nonnutritional conditions, such as inflammation, acute or chronic comorbidities or infec tious events, and proteinuria, especially if residual renal function with marked proteinuria persists. 21 A study by de Mutsert et al. 22 reported that the mortality risk associ ated with low levels of albumin could partially be explained by levels of Creactive protein, but less so by normalized protein catabolic rate or subjective global assessment. Indeed, anorectic patients who display no inflammation or cachexia may have normal serum levels of albumin. 23 Although the debate continues as to whether low serum levels of albumin in patients with CKD are a surrogate of inadequate protein intake or other conditions related to PEW, such as inflammation or comorbidity, 21 there seems to be less disagreement regarding the consistent associa tion of hypoalbuminemia with poor outcomes in dialysis patients and those with nondialysisdependent CKD. 20 Reports indicate that patients attending dialysis clinics that provide superior care and have a good performance exhibit higher serum albumin levels and better survival rates than patients who attend clinics with an inferior performance. 12, 24 Despite ongoing studies to determine whether serum albumin concentration is a nutritional marker or not, the actionability and responsiveness of serum albumin levels to nutritional interventions are far more relevant. Longevity has consistently been observed in those patients with CKD who have a better nutritional status, including larger muscle mass, 25, 26 fat mass, 27 better appetite, 28, 29 and higher protein intake. 30 One study has suggested that imposing dietary protein restrictions to control serum phosphorus levels might cause harm and increased mortality, especially if associated with decreased normalized protein catabolic rate and serum albumin levels; 31 this finding could explain paradoxical observations such as the observed increased survival of patients who do not adhere to the strict rules imposed by clinics that prohibit incenter food ingestion during dialysis therapy. 4 Other nutritional markers of PEW A serum prealbumin level of <300 mg/l is another indica tor of PEW, and a strong predictor of outcome in patients with CKD. 16 Two studies have shown that a change in serum levels of prealbumin over time is associated with corresponding changes in survival of patients on dialy sis. 16, 17 One of these studies found that although baseline serum prealbumin concentration might not be supe rior to albumin in predicting mortality in hemo dialysis patients, prealbumin concentrations of <200 mg/l are associated with an increased risk of mortality even in patients with normal albumin levels, and a decrease in serum prealbumin levels over 6 months is indepen dently associated with an increased risk of death. 16 Other nutritional indicators that predict survival in patients on dialy sis include serum transferrin levels 32, 33 and nutri tional scoring systems, such as subjective global assess ment 34 and the malnutrition-inflammation score, which also correlate with quality of life (Box 1). 18 Some bio markers exhibit low levels in the setting of inflamma tion even without undernutrition. 35 However, among these biomarkers, serum albumin concentration is measured most frequently (at least monthly to quar terly in most countries in patients on dialysis), making it the most readily available biomarker of PEW.
Ameliorating the PEW-death association Is the association between PEW and death causal or an epiphenomenon? Whereas the debate on causality has continued, 21, 36, 37 in our opinion a more clinically relevant and timely question is whether a nutritional intervention can increase serum albumin levels or correct PEW in patients with CKD, and by doing so, does survival and quality of life improve? We believe that the answer to both parts of the question is a cautious "yes" based on the experimental data, [38] [39] [40] [41] [42] [43] [44] despite the fact that no single welldesigned randomized, controlled trial with adequate sample size has yet examined this simple question. Importantly, however, the field of nutritional support (such as nutrition for patients with terminal cancer, for patients who have undergone surgery, or geriatric or dis abled populations) is based on the premise that provision of nutritional support improves the patient's immedi ate or shortterm outcomes, independent of the cause of wasting and cachexia, whereas the longterm effects are less clear. 35 Although we do not deny the paucity of randomized, controlled trials and the difficulties sur rounding the feasibility of nutritional interventions or testing their effects on hard outcomes, 45 we believe that inadequate nutritional support during hemodialysis treatments, which might have catabolic effects, is not consistent with good practice.
Dialysis meals and oral supplements
The recommended dietary energy intake (DEI) for patients undergoing hemodialysis and peritoneal dialy sis is 30-35 kcal/kg per day. 19, [46] [47] [48] [49] Suggested mean dietary protein intake (DPI) is 1.2 g/kg per day in patients on hemodialysis, and 1.3 g/kg per day in patients on peri toneal dialysis. 19, [46] [47] [48] [49] Most patients on dialysis, however, have a lower DEI and DPI than the recommended intake. In 1,901 adult patients on the HEMO Study, the mean DEI and DPI were 23.2 ± 9.5 kcal/kg per day and 0.96 ± 0.43 g/kg per day, respectively, on nondialysis days, and 22.2 ± 9.6 kcal/kg per day and 0.90 ± 0.41 g/kg per day, respectively, on dialysis days. 50 Nutritional support for patients on dialysis should make it possible to ensure nutritional intake is in accordance with the current guidelines. Oral supplementation can provide an additional 7-10 kcal/kg per day of energy and 0.3-0.4 g/kg per day of protein, which makes it possible to meet the recommended targets of both DEI and DPI. To reach such energy and protein levels, oral supplements should be given two to three times a day, preferably 1 h after main meals. We have identified clinical trials with at least 10 participants in which the effects of enteral nutritional interventions were examined in malnourished patients on dialysis (Tables 1-4) . 17, 40, 43, 44, In most of these studies, enteral therapy was associated with improved nutritional status or other clinical outcomes.
Enteral nutrition for hemodialysis patients Among hemodialysis patients, who comprise over 90% of all dialysis patients in the USA, PEW is common and associated with poor outcomes. 2 A prospective study by Caglar et al. 71 included 55 malnourished patients on hemodialysis who received conventional nutri tion counseling for 3 months, followed by 6 months of thriceweekly intake of a 237 ml oral nutritional supplement specifically designed for patients on dialy sis (Nepro ® , Abbott Nutrition, Columbus, OH, USA), which was provided during dialysis in the clinic to ensure adherence. Substantial increases in serum albumin and pre albumin concentrations were observed: from 33.3 ± 3.2 g/l and 261 ± 86 mg/l at baseline, to 36.5 ± 2.6 g/l and 307 ± 74 mg/l, respectively at 6 months. 71 In another incenter prospective controlled trial of 40 hemodialysis patients with hypo albuminemia (albumin concentra tion ≤38 g/l), 20 patients received Nepro ® accompanied by an additional liquid anti inflammatory and anti oxidative oral supplement that included borage oil and fish oil (Oxepa ® , Abbott Nutrition). 40 After 4 weeks of thriceweekly nutritional intervention during the hemo dialysis treatment, the pretrial serum albumin level of 34.5 ± 3.1 g/l increased to 36.8 ± 3.4 g/l (P = 0.02). 40 Of the studies listed in Table 1 , eight of nine random ized trials using serum albumin concentration as a surro gate outcome measure reported statistically significant improvements in hypoalbuminemia. 17, 44, [51] [52] [53] [54] [55] 57 Serum albumin concentration did not considerably increase in the study by Fouque et al., 56 but high serum levels of albumin and prealbumin were observed in those who achieved increased dietary protein intake. In the trial by Cano et al., 17 186 malnourished patients undergoing hemo dialysis were randomly assigned to intradialytic parenteral nutrition versus no intradialytic parenteral nutrition, while both arms received oral supplements. Despite apparently negative results for intradialytic parenteral nutrition, serum levels of albumin and pre albumin increased in both groups treated with oral supple ment therapy, and greater survival was observed in those whose serum prealbumin concentration increased by >30 mg/l at 3 months. 17 These data underline the importance of measuring serum pre albumin levels in the followup of patients receiving nutritional support. Leon et al. 55 randomly assigned 180 patients on hemodialysis to usual care with targeting of specific nutritional barri ers, including poor nutritional knowledge, poor appetite, help needed with shopping or cooking, low fluid intake, inadequate dialysis dose, depression, difficulty chewing or swallowing, gastrointestinal symptoms and acidosis. As part of the intervention, patients with a poor appetite or low fluid intake were given limited amounts of oral nutritional supplements, such as commercially available enteral nutrition drinks and cookies. After 12 months, patients in the intervention group had greater increases in serum albumin levels, energy intake and protein intake than the patients in the control group. 55 Intradialytic nutrition for hemodialysis patients Intradialytic and incenter nutrition deserve special comment. Inadequate food intake, especially on hemo dialysis treatment days, is common among patients in the USA, 50 whereas meals are routinely served during ‡ These values may be considered within the normal range in patients with nondialysis-dependent CKD or in other patient populations.
§ Racial and ethnic variations should be considered; e.g. low BMI ranges might be considered within the acceptable range in Asian patients with CKD. Weight must be edema-free body mass (e.g. postdialysis dry weight). || Distinction between subcutaneous and visceral fat should be considered.
¶ In relation to the 50 th percentile of a reference population. # In patients undergoing thrice-weekly hemodialysis who have minimal residual renal function a low predialysis serum creatinine concentration of <442 µmol/l could be a sign of sarcopenia. Creatinine appearance is influenced by both muscle mass and meat intake. **Assessed by dietary diaries and interviews; protein intake in patients on dialysis can be estimated by calculation of normalized protein equivalent of total nitrogen appearance as determined by urea kinetic measurements. Abbreviations: CKD, chronic kidney disease; PEW, protein-energy wasting.
hemodialysis treatment sessions in many other countries. Until the late 1980s, meals during dialysis were routine practice in the USA and some Veterans Administration hospitals still provide meal trays during dialysis shifts. However, some dialysis clinics in the USA have strict rules against food and drink intake during hemo dialysis treatment. When nephrologists and dialysis care pro viders in the USA were asked as to why meal trays for patients do not exist during dialysis treatments, the most common answers were the following: postprandial hypotension; risk of choking or aspiration; infection control and hygiene issues, including fear of fecal-oral transmission of diseases (such as hepatitis A); increased staff burden and distraction; and diabetes mellitus and phosphorus control (Table 5) . 81 Meals and nutritional supplements are routinely offered, for free in most part, to the majority of out patients on hemodialysis in many European and SouthEast (28) Case (13) Control (15) Serum albumin levels increased from 26.4 g/l to 30.5 g/l in the study group vs 26.6 to 28.0 g/l in the control group DPI, DEI and nPNA increased significantly more in the study group than in the control group Malnutrition decreased 6% in the control group vs 28% in the study group Most important predictors of serum albumin concentration: egg albumin-based ONS and DPI (P <0.05) Asian countries. Dialysis patients in Germany invariably eat during their hemodialysis treatments and have higher serum levels of albumin and greater survival than their US counterparts. 82 Advantages of in-center meals and supplements Despite the concerns of nephrologists and dialysis care providers regarding meals during dialy sis, over the past few years a number of dialysis clinics have provided and even encouraged oral nutritional supple ment. This change in practice has coincided with the emergence of several studies indicating that provision of oral nutri tional supplements with a high protein content during hemodialysis is associated with an increase in serum albumin levels. 71, [83] [84] [85] In addition to improving nutri tional status, providing incenter meals and/or oral nutritional supplements also improves patient adher ence and satisfaction. Patients might be more motivated to attend treatments sessions if they know that a meal will be provided. As many patients already ignore the regulations that prohibit eating in some dialysis clinics and still bring their own foods (including those with a high phosphorus content), dialysis clinics could provide a more appropriate food or supplement with a high protein content and low salt content, low phosphorus to protein ratio, 86 and low potassium content, 87 together with administration of a phosphatebinder regimen and multivitamins at the time of meal or ingested supplement. The educational value of the meal provided in the clinic could be an important influence on patient adherence to dietary recommendations.
Benefits of intradialytic nutrition
Strong evidence indicates that patients on dialysis are subject to multiple metabolic and nutritional derange ments that lead to a chronic and persistent negative nutrient balance. 88 In addition, laborintensive studies of protein turnover have indicated that the protein catabolic effects of hemodialysis treatment are profound, affecting the homeostasis of both wholebody and skeletal muscle protein. 89 Patients undergoing dialysis experience recur rent infections, acute cardiovascular events, and frequent CKD-specific ONS showed increased weight (1.2 kg) and albumin levels (1.0 ± 0.5 g/l); weight change correlated with DEI Unchanged prealbumin and cholesterol levels Good compliance and tolerance *Some randomized crossover studies were included. Abbreviations: CKD, chronic kidney disease; DEI, dietary energy intake; DPI, dietary protein intake; EAA, essential amino acid; HD, hemodialysis; ONS, oral nutritional supplement; PCR, protein catabolic rate; PEW, protein-energy wasting; SGA, subjective global assessment.
hospitalizations, in addition to underlying comorbidities. These factors lead to inadequate nutrient supply, altered metabolism, and increased nutrient requirements, mim icking a state of nearstarvation. 90 A commonly ignored reason for the observed nutrient deficiency is the inevit able loss of amino acids into the dialyzate during hemo dialysis, which is equivalent to 6-8 g per dialysis session, or 6.5 kg per year. 91, 92 If the aim of muscle protein catab olism during hemodialysis is to maintain plasma levels of amino acids 93 and to provide amino acid substrate for acutephase protein synthesis, 94, 95 oral supplementation of amino acids could be a simple and appropriate method to deliver amino acids to the splanchnic bed. 96 The catabolic consequence of dialysis therapy can be mitigated, or even converted to, an anabolic state by provi sion of intradialytic nutritional supplementation, especially in the form of meals or oral supplements. Studies have been carried out that assess the acute physio logical response to dialysis and administration of intradialytic oral supple mentation, including stable isotope kinetic studies and those measuring readily available nutritional markers such as serum levels of albumin and pre albumin. 97, 98 Veeneman et al. 98 examined wholebody protein metabolism by primed, constant infusion of l [1 13 C]valine to ascertain whether consumption of a protein and energyenriched meal improved protein balance during hemodialysis. Feeding changed the negative wholebody protein balance observed during fasting to a positive protein balance, and strongly improved wholebody protein balance, probably owing to the increased concentrations of amino acids in the blood. 98 In another study of protein turnover, Pupim et al. 83 showed that in eight malnourished patients under going hemodialysis, highly positive wholebody net protein balance during hemodialysis and improvement of skeletal muscle protein homeostasis was achieved with both intradialytic parenteral nutrition and an intradialytic oral nutritional supplement compared with during the control period. Oral therapy during hemodialysis resulted in persistent anabolic benefits for muscle protein metab olism in the posthemodialysis phase, whereas the anabolic benefits of intradialytic parenteral nutrition dissipated during the same period (Figure 3) . 83 These data support both the anabolic and anticatabolic roles of intradialytic enteral nutritional support. Welldesigned controlled trials are now needed to examine hard clinical end points such as survival.
Enteral nutrition during peritoneal dialysis
When devising a plan for enteral support for patients undergoing peritoneal dialysis, a few important factors need to be considered. First, peritoneal dialysis is associ ated with obligatory glucose absorption from the dia lyzate, which provides 300-600 kcal per day over that obtained through the diet. These calories obtained through glucose depend on the peritoneal transport rate and dialysis prescription, and partly compensate for the low oral energy intake of patients on peritoneal dialy sis. 99 Second, patients on peritoneal dialysis lose 5-7 g of protein per day in the dialyzate effluent; these losses are substantially increased during episodes of peritonitis.
100,101
The peritoneal protein losses contribute, in part, to the lower serum levels of albumin and higher daily protein requirements observed in patients on peri toneal dialysis than in those treated with hemodialysis. 102 However, the protein losses are not large enough to make a substantial contribution to PEW. 99 Third, intraperitoneal administra tion of dialyzate has been shown to worsen gastric emp tying, including in nondiabetic patients with endstage renal disease, and could contribute to the inadequate oral intake as well as intolerance of oral supplements frequently seen in these patients. 103 At least 10 studies of patients on peritoneal dialysis have examined the effect of oral nutritional interventions on measures of nutritional status. 44, 53, 54, 57, 74, [76] [77] [78] [79] [80] Although these studies show mixed results, some generalizations can be made. First, in a singlemeal study, administration of oral supplements did not lead to a substantial decrease in dietary intake. 79 This result indicates that oral supplements can increase the total daily energy and protein intake of patients on peritoneal dialysis. Second, a large propor tion of patients are either intolerant to, or non adherent with, the supplement prescription; 44, 53, 76, 78, 80 in some studies this intolerance or nonadherence affected over 50% of the partici pants. 44, 78 This high dropout rate has led many studies to be underpowered to detect statistically signifi cant improvements in PEW and also highlights the limitations in using oral supplements. Third, in adherent patients who were able to tolerate supplements, consider able improvements were seen. 53, 54, 76, 80 For example, use of oral nutritional supplements in the randomized controlled trial by TeixidóPlanas et al. 80 resulted in substantial increases in triceps skinfold thickness, circumference of the midarm muscle, and lean body mass in the as treated analysis. Fourth, studies that have examined high biologicalvalue supplements, such as calcium caseinate or egg albuminbased supplements, showed greater bene fits than studies using standard oral supplements. 53, 54, 78, 80 This differ ence could be explained, in part, by increased tolerance and therefore improved adherence to supple ments. Taken together, these data indicate that an increase in enteral intake is feasible and could improve PEW in adherent patients on peritoneal dialysis.
Nutrition in CKD patients with diabetes
Although diabetes mellitus is independently associated with poor outcomes and increased mortality, the presence of CKD greatly increases the mortality rate, 104 indicating that CKD itself is a strong independent determinant of poor outcomes. Despite concerns regarding the glycemic burden of nutritional interventions in patients with dia betes mellitus, such considerations might have less rele vance in malnourished patients on dialysis. Indeed, in approximately onethird of patients on dialysis with dia betes mellitus, a state of 'burntout diabetes' is observed in which frequent episodes of hypoglycemia necessitate a decrease or even total discontinuation of most or all dia betic medications, including insulin injections and oral hypoglycemic agents. 105, 106 Many of these patients exhibit normal to low levels of hemoglobin A 1c , even without medication for diabetes mellitus and when they originally suffered from diabetic nephropathy as the etiology of their CKD. 107, 108 Some studies have found no association between glycemic control and outcomes in patients on dialysis. 109, 110 Hemodialysis sessions themselves can lead to moderate to severe intra dialytic hypoglycemia. 111, 112 Hypoalbuminemia and intra dialytic hypotension were found to be the main predictors of intra dialytic hypo glycemia in patients with dia betes melli tus undergoing hemodialysis in one study. 111 Therefore, in the USA and many other countries, the dialyzate bath includes high concentrations of glucose (11.1 mmol/l) to avoid hypo glycemia during hemo dialysis. 112 In our opinion, a history of diabetes mellitus is not a contraindication for oral nutri tional therapy or meals during hemodialysis, and should not be a reason to withhold nutritional interventions, especially among dialysis patients with hypo albuminemia and normal to low levels of hemoglobin A 1c .
Nutritional therapy and ketoanalogues
PEW is also common in patients with nondialysis dependent CKD, 3 in whom a decline in protein and calorie intake usually develops when glomerular filtra tion rate (GFR) falls to <25-35 ml/min/1.73 m 2 , 113 although such changes may start when the GFR is as high as 55 ml/min/1.73 m 2 . 114 Although the influence of actual protein and energy intake on outcomes is not well studied in patients with nondialysisdependent CKD, various bio chemical markers of nutrition and inflammation corre late with increased mortality and rates of cardio vascular events (Figure 4) . 20, [115] [116] [117] Enteral protein intake has, however, not been wellexamined as a therapeutic strategy in this patient population, largely because of the belief that a low intake of protein is necessary to slow the progres sion of CKD and improve outcomes. 118, 119 A high intake of protein could affect GFR through various mechanisms, including alterations of glomerular hemo dynamics. 120 Restricted protein intake (for instance <0.8 g/kg per day or even <0.6 g/kg per day [121] [122] [123] [124] as compared with the 1.2 g/kg per day that is recommended for patients on dialysis), in particular in combination with keto analogues of amino acids, has been used successfully to delay the progres sion of CKD in some, 125, 126 but not all, 127, 128 studies. The benefit of a low protein diet might, at least in part, be related to its low phosphorus content, 121, 122 as a decreased phosphorus burden can slow the progression of renal failure and improve other outcomes in indivi duals with nondialysisdependent CKD. [129] [130] [131] Whereas a low protein diet can be implemented by adhering to dietary restriction, manufactured disease specific and hypercaloric oral supplements can improve management of CKD without causing malnutrition.
However, very few studies have examined the use of oral nutritional supplements in patients with nondialysis dependent CKD. In a Spanish study of 22 patients with non dialysisdependent CKD on a low protein diet (0.6 g/kg per day), half the patients also received a portion of their prescribed dietary proteins and calories via a low protein and hypercaloric supplement for 6 months. 132 In the group receiving the oral supplement, the nutritional measures were better and their protein intake seemed to be closer to the target low protein diet objective than that of the control group. Patients receiving the supplement also had better adherence and a smaller decrease in renal function than the control group. 132 The Modification of Diet in Renal Disease study exam ined the effect of a low protein diet versus a very low protein diet supplemented with keto acids and amino acids on GFR and on the incidence of endstage renal disease and death. 133 Intention to treat analyses did not indicate any benefit with the very low protein diet. 133 In a series of post hoc analyses of the Modification of Diet in Renal Disease study, a lower achieved protein intake (0.5-1 g/kg per day) was associated with slowing of the progression of CKD, 134 but the very low protein diet supplemented with a mixture of essential keto acids and amino acids (0.28 g/kg per day) compared with a low protein diet (0.58 g/kg per day) was associated with increased mortality and accelerated progression of renal failure. 135 As it is unclear why some patients achieved low protein intake but others did not, 134, 135 these results might not be construed as conclusive evidence towards the benefit or harm of a low protein diet with or without ketoanalogues. Nevertheless, enthusiasm about the use of ketoanalogues seems to be increasing, [136] [137] [138] [139] [140] as reflected in a consensus statement that mentions bene ficial effects that include: a decrease in uremic toxins; reduced protein uria; salutary effects on mineral and bone dis orders and on lipid profile; as well as a potential delay in the progression of kidney disease and dialysis initiation with reduced likelihood of engendering malnutrition. 141 We believe that ketoanalogues could have a role in the treatment of patients with nondialysisdependent CKD, especially if combined with a tailored low protein diet with highbiologicalvalue supplements or oral nutri tional supplements specifically designed for this patient population. 132 Emerging data indicate that in patients on peritoneal dialysis, ketoanalogues could contribute to preserving residual renal function, 136 although their role in the treatment of patients on maintenance hemo dialysis with minimal residual renal function is question able. Caution with regard to the use of ketoanalogues should be exercised even in patients on peritoneal dialy sis as longterm safety of these dietary regimens in the clinical setting has not yet been established.
Nutritional therapy in transplant recipients
After a successful renal transplantation with a function ing allograft, patients normally experience a dramatic increase in appetite and weight gain. 142, 143 However, in many transplant recipients, especially in those with chronic allograft nephropathy, a worsening nutritional status is observed similar to that seen in patients with nondialysisdependent CKD. Several specific factors relating to transplantation can potentially induce PEW in kidney transplant recipients in addition to condi tions related to uremia. The immune response to the graft, the frequency and severity of rejection events, the degree of impaired renal function, and the use of immuno suppressive regimens might all contribute to the pathways that cause PEW. 144 The deleterious effects of PEW on clinical outcomes might be mediated by the inflammatory response, leading to worsening anemia, 145 erythropoietin hyporesponsiveness 146 and de novo dia betes mellitus. 147 Examining the nutritional status of transplant recipients and the influence of a transplant on clinical outcomes has been hampered by a lack of clini cally applicable and standardized methods to assess the presence of PEW in these patients.
Investigators of a cohort study of 993 prevalent renal transplant recipients examined the relationship between nutritional status by means of assessing the malnutritioninflammation score and relevant clinical indicators. 144 The malnutrition-inflammation score negatively corre lated with abdominal circumference and positively corre lated with markers of inflammation, including serum levels of Creactive protein, interleukin 6, and tumor necrosis factor; the malnutrition-inflammation score reflected both PEW and inflammation in kidney transplant recipients. 144 Emerging data indicate that a poor nutritional status before or after renal transplanta tion is associated with poor outcomes, including increased mortal ity and reduced graft survival. [148] [149] [150] [151] We recom mend, therefore, that the same enteral nutritional support should be given to transplant recipients as for patients with nondialysisdependent CKD.
Enteral nutrition in children with CKD
PEW often presents as growth retardation in children with CKD. One of the major goals in the treatment of infants and children with CKD is to achieve normal growth and development. Even fairly mild CKD can cause substantial anorexia in children. 152 Poor growth owing to inadequate food intake has been observed in infants with a GFR as high as 70 ml/min/1.73 m 2 . 153 Meeting normal nutritional requirements in infants with CKD can be diffi cult: the nutrition care plan requires frequent monitoring and adjustments in response to changes in the child's nutri tional status, age, development, anthropometrics, food preferences, residual renal function, renal replacement therapy, medications, and psychosocial status. 154 In the majority of cases, infants with severe CKD will require tube feeding.
Nutrition), contain low amounts of phosphorus and potassium and are preferred for some infants with CKD. To meet requirements, commercial carbohydrate and/or fat products can be added to feedings to increase their standard energy density from 20 kcal/oz or 0.67 kcal/ml to as high as 60 kcal/oz or 2 kcal/ml without substantially increasing electrolyte and mineral content. A gradual increase in energy density often improves tolerance.
Infants and children with CKD who experience anuria and polyuria have very different food and fluid require ments from those who do not have these conditions. Both these subsets of children require adequate nutrition to maximize growth. Children with polyuria may be given and maintained on a diluted formula and undergo pre emptive kidney transplantation, thus never requiring HR for mortality
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Adjusted; P for trend <0.001
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Box 2 | Improving nutritional status in dialysis patients
Oral nutritional interventions ■ Improving dental health, including use of dentures REVIEWS dialysis. However, it is important to monitor the amount of nutrients being delivered to infants with polyuria. Those who are oliguric or anuric often require frequent (sometimes daily) dialysis to offset the largevolume feeds that occur with standard formulas. In the absence of pedi atric renal feeding supplements, adult renal products that are available with normal and reduced protein content, and designed to be calorie dense and low in minerals and electrolytes, can be recommended for children who are aged >4 years; these adult supplements have also been successfully used at diluted strength in children aged <1 year. 156 A study showed that children with CKD and hyperkalemia demonstrated improved growth rates while receiving adult renal formulas, which were welltolerated and effective in lowering potassium exposure. 157 The early anticipation and correction of PEW, espe cially in infants, is important to avoid loss of growth potential. Initial studies demonstrated that growth of infants with CKD is compromised when energy intake falls below 80% of the recommended daily allowance. 158 Increasing energy intake to the recommended daily allow ance can increase weight gain and stabilize growth rates in children of all ages and achieve catchup growth in infants who are treated before they reach 2 years of age. 159 According to some studies, however, the energy require ments of children with CKD have not been shown to differ from healthy children, 160 nor is there evidence that children with CKD will show improved growth if their intake exceeds recommended amounts for healthy chil dren. 154 Growth hormone therapy is indicated and widely accepted for treatment of growth retardation in chil dren with CKD, but its use is only justified after ensur ing adequate nutritional management. 161, 162 Given the importance of growth and development in children, we encourage monitored incenter enteral nutrition therapy for all infants and children who require maintenance dialysis treatment.
Beyond protein and calorie control
Enteral nutritional support can provide a variety of macro nutrients and micronutrients in addition to calories and protein. Earlier studies examined the effect of essential amino acid supplementation on the nutritional status of patients with CKD. 43, 44, 51, [58] [59] [60] 69, 70 Supplemental fish oil and other sources of omega 3 fatty acid have been tested. In a randomized trial by Tietze et al., 62 fish protein (8 g daily) and fishbased ingredients were tested for up to 6 months with some success. KalantarZadeh et al. 40 supplemented a thriceweekly CKDspecific supplement with an additional 237 ml can of fish oil, borage oil, and other antioxidative and antiinflammatory ingredients (originally designed for patients with acute pulmonary failure 163 ). Fanti et al. 73 showed that an oral soy isoflavone supplement taken for 8 weeks lowered serum levels of Creactive protein in patients undergoing hemodialysis. In a randomized trial, Ewers et al. 164 examined the effects of oral unsaturated fat for 6 weeks in 14 patients undergoing hemodialysis and found that levels of Creactive protein were decreased. Native (nutritional or inactive) vitamin D compounds, such as chole calciferol, and other anti oxidative vitamins can also be used in the form of multivitamins or as added ingredients to oral nutritional supplements. 40 Other under utilized and as yet undiscovered dietary and pharmaco logical ingredients are likely to be used as adjunct to conventional calorie and protein in the future.
Nonenteral nutritional interventions
In addition to meals and nutritional supplements during hemodialysis, there are other potential interventions to improve the nutritional status of patients, including appe tite stimulants with or without antidepressant properties (megesterol, 165 ghrelin, 166 and mirtazapine 167 ), anabolic hormones (testosterone) and growth factors, 168 and anti oxidative and antiinflammatory agents (pentoxifylline and cytokine modulatory agents) (Box 2). 169, 170 In patients undergoing hemodialysis with severe hypoalbuminemia (albumin concentration <30 g/l) who do not improve with oral interventions, even with adjunctive pharmacological therapy, or those in whom enteral interventions are not possible, parenteral interventions such as intradialytic par enteral nutrition should be considered. 97, 171 Intradialytic parenteral nutrition is especially effective in patients with such low serum albumin values. 39 Finally, nonnutritional The target of total protein intake should be a DPI of ≥1.2 g/kg per day for patients on dialysis, and 0.6 g/kg per day for patients with nondialysis-dependent CKD, including renal transplant recipients. Abbreviations: CKD, chronic kidney disease; DEI, dietary energy intake; DPI, dietary protein intake; IDPN, intradialytic parenteral nutrition; K, potassium; MIS, malnutrition-inflammation score; Na, sodium; P , phosphorus; PEG, percutaneous endoscopic gastrostomy; RTR, renal transplant recipient; SGA, subjective global assessment.
interventions, such as dialysis treatment modalities and techniques that lead to decreased inflamma tion or protein loss, should also be considered.
172,173

Conclusions
In patients with CKD, PEW is a condition that is distinct from undernutrition and is associated with inflammation, increased resting energy expenditure, low levels of albumin and prealbumin, sarcopenia, weight loss and poor clinical outcomes. Although the debate on the relative contribution of inflammation versus mal nutrition to the development of PEW continues, dietary interventions and nutritional support seem effective in mitigating or correcting PEW and improving outcomes in patients with CKD. Another ongoing debate is that regarding the recommenda tion of low protein intake with or without amino acid supple mentation or ketoanalogues for patients with nondialysis dependent CKD. 174 Based on the data discussed in this Review, we suggest provision of maintenance meals and dietary supplements during each hemodialysis session and visit to the dialysis clinic. A maintenance regimen can ensure adequate protein intake and reinforce similar dietary habits at home. If serum levels of albumin remain <40 g/l despite maintenance meals or oral supplements, then the intensity of the dietary protein intake should be increased and other potential causes of hypoalbuminemia, such as persistent inflammation and urinary albumin losses, should be examined. Alternatively, tube feeding can be considered in those not capable of swallowing or at high risk of aspiration. Several ongoing randomized, controlled trials are examining the role of CKDspecific oral nutritional support 175 or incenter meals during hemodialysis, with a focus on phosphorus control. 176 We recommend that all patients with CKD are assessed peri odically (monthly or quarterly) for the presence of PEW and be offered oral nutritional support following the algo rithm shown in Figure 5 . We also recommend the frequent intake of small amounts of proteinrich liquid oral supple ment with prescribed pills to replace water, which has been shown to improve outcomes in elderly individuals and those in nursing homes. 177 As we move towards longer hemodialysis sessions, 178 and in anticipation of drastic changes in practice patterns as a result of implementation of the expanded bundle payment system in the USA, we need to rethink meals and oral supplements provided during dialysis therapy. Although meals during dialysis are routine practice in Europe and most other countries, the majority of patients on dialysis in the USA are deprived of nutri tional intervention during dialysis. The consistent strong association of nutritional status, and in particular serum albumin levels, with survival in patients with CKD has been clearly shown. Given the fact that the provision of meals and oral supplements would require only a small fraction of the funds currently used for the expensive medications given to patients on dialysis with no proven outcome modification, 179 providing meals or oral nutri tional supplements and other nutritional interventions to patients with CKD is the most promising way to increase serum albumin concentration and improve longevity and quality of life in this patient population.
Review criteria
We reviewed the literature to identify all clinical trials with at least 10 participants in which the effects of enteral (oral or tube-feeding) nutritional interventions were examined in malnourished patients with chronic kidney disease. Both the PubMed and Google Scholar databases were searched for all studies published or reported in English or with an English abstract since 1970. One paper in Spanish was considered relevant and translated into English. Full-text articles deemed pertinent were selected and the reference lists of the identified reports and articles were searched for further material.
